多基因检测测序确定男性乳腺癌患者新的种系突变谱。

Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients.

作者信息

Al Saati Ayman, Vande Perre Pierre, Plenecassagnes Julien, Gilhodes Julia, Monselet Nils, Cabarrou Bastien, Lignon Norbert, Filleron Thomas, Telly Dominique, Perello-Lestrade Emilie, Feillel Viviane, Staub Anne, Martinez Mathilde, Chipoulet Edith, Collet Gaëlle, Thomas Fabienne, Gladieff Laurence, Toulas Christine

机构信息

Oncogenetics Laboratory, Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse, France.

DIAD, Inserm, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.

出版信息

Int J Mol Sci. 2023 Sep 20;24(18):14348. doi: 10.3390/ijms241814348.

Abstract

Even though male breast cancer (MBC) risk encompasses both genetic and environmental aetiologies, the primary risk factor is a germline pathogenic variant (PV) or likely pathogenic variant (LPV) in and/or genes. To identify new potential MBC-specific predisposition genes, we sequenced a panel of 585 carcinogenesis genes in an MBC cohort without PV/LPV. We identified 14 genes carrying rare PVs/LPVs in the MBC population versus noncancer non-Finnish European men, predominantly coding for DNA repair and maintenance of genomic stability proteins. We identified for the first time PVs/LPVs in (pre-mRNA processing), (transcription regulation), and (maintenance of genomic stability) as well as in genes involved in other cellular processes. To study the specificity of this MBC PV/LPV profile, we examined whether variants in the same genes could be detected in a female breast cancer (FBC) cohort without PV/LPV. Only 5/109 women (4.6%) carried a PV/LPV versus 18/85 men (21.2%) on these genes. FBC did not carry any PV/LPV on 11 of these genes. Although 5.9% of the MBC cohort carried PVs/LPVs in and neither of these genes were altered in our FBC cohort. Our data suggest that in addition to , other genes involved in DNA repair/maintenance or genomic stability as well as cell adhesion may form a specific MBC PV/LPV signature.

摘要

尽管男性乳腺癌(MBC)的风险包括遗传和环境病因,但主要风险因素是BRCA1和/或BRCA2基因中的种系致病变异(PV)或可能的致病变异(LPV)。为了鉴定新的潜在MBC特异性易感基因,我们对一组585个致癌基因进行了测序,该组基因来自一个没有BRCA PV/LPV的MBC队列。我们在MBC人群与非癌症的非芬兰欧洲男性中鉴定出14个携带罕见PVs/LPVs的基因,这些基因主要编码DNA修复和基因组稳定性维持蛋白。我们首次在PRPF31(前体mRNA加工)、ZNF365(转录调控)、MCPH1(基因组稳定性维持)以及参与其他细胞过程的基因中鉴定出PVs/LPVs。为了研究这种MBC PV/LPV谱的特异性,我们检查了在一个没有BRCA PV/LPV的女性乳腺癌(FBC)队列中是否能检测到相同基因中的变异。在这些基因上,只有5/109名女性(4.6%)携带PV/LPV,而男性为18/85名(21.2%)。FBC在其中11个基因上没有携带任何PV/LPV。尽管MBC队列中有5.9%的人在ATM和PALB2中携带PVs/LPVs,但在我们的FBC队列中这两个基因都没有改变。我们的数据表明,除了BRCA1/2之外,其他参与DNA修复/维持或基因组稳定性以及细胞黏附的基因可能形成特定的MBC PV/LPV特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d8d/10531866/e8ba4cdf3ab5/ijms-24-14348-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索